Views & Analysis Could AI create a brave new world of pharma R&D? Barely a week goes by without one big pharma or biotech announcing that it is using AI to develop new medicines.
Events Partner Content 13th Annual Pharma Resource Planning and Portfolio Managemen... Prioritizing Projects with Tools, Data, and Governance
Partner Content Partner Content 3rd Annual AI-ML Drug Discovery & Development Summit Discover Case Studies of Machine Learning in Action
Partner Content Partner Content Understanding the evolving CAR-T market In August 2017, Novartis made history after receiving FDA approval for Kymriah, the world’s first chimeric antigen receptor T-cell (CAR-T) therapy.
News GBL joins CVC in €10.7bn takeover bid for Recordati A consortium of investors has made a €10.7bn offer to take Italian pharma Recordati private, but some analysts are sceptical the deal will go through.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
